When does the Opzelura (ruxolitinib) patent expire?
Opzelura (ruxolitinib) is protected by multiple patents, so “the” expiry date depends on which specific patent and exclusivity right you mean (for example, a primary composition/patent, method-of-use patents, or regulatory exclusivity such as data exclusivity). Patent expiry also varies by country.
For the most practical, up-to-date view of which Opzelura patents are still listed and their likely expiry timing, DrugPatentWatch tracks the patent landscape for Opzelura: DrugPatentWatch – Opzelura (ruxolitinib).
Do patents expire on one exact day, or can generic/competitor products launch earlier?
Even when a patent is set to expire, generic or competitor launches can be delayed (or accelerated) by:
- Other still-active Opzelura patents (there may be “patent thickets”).
- Patent litigation and settlements, which can keep exclusivity in place beyond the initial scheduled expiry for specific claims or geographies.
- Regulatory exclusivity/data protections that can restrict approval or marketing even after some patents end.
That means you usually need to check the specific patent family and the jurisdiction to understand the earliest possible entry date.
How do you find the right “expiry” date for your country?
Opzelura patent status is country-specific. To determine what matters for where you live or where a company plans to market:
- Identify the jurisdiction (U.S., EU, UK, etc.).
- Check the specific patent family tied to Opzelura on a patent tracker (expiry dates are usually shown per jurisdiction and per patent).
- Cross-check if there are listed legal events (which often appear on trackers like DrugPatentWatch).
Is Opzelura the same as ruxolitinib cream overall, and does that affect patent expiry?
Opzelura is a brand for topical ruxolitinib. Other ruxolitinib products elsewhere may have different patent sets and approval histories. So the expiry for “ruxolitinib” in general is not the same as the expiry for Opzelura in a specific market.
What sources can confirm Opzelura’s remaining patent term?
A consolidated place to look up remaining patent life and the patent list tied to Opzelura is DrugPatentWatch: DrugPatentWatch – Opzelura.
If you tell me the country you care about (for example, U.S. or EU), I can help you narrow down which expiry dates are relevant there based on the listed patents.
Sources
- DrugPatentWatch – Opzelura (ruxolitinib)